SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000792977-17-000030
Filing Date
2017-08-04
Accepted
2017-08-04 16:04:33
Documents
82
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amag6301710-q.htm 10-Q 1479167
2 EXHIBIT 31.1 ex311q22017.htm EX-31.1 16294
3 EXHIBIT 31.2 ex312q22017.htm EX-31.2 16052
4 EXHIBIT 32.1 ex321q22017.htm EX-32.1 8299
5 EXHIBIT 32.2 ex322q22017.htm EX-32.2 8452
  Complete submission text file 0000792977-17-000030.txt   9066872

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amag-20170630.xml EX-101.INS 2119803
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20170630.xsd EX-101.SCH 68343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20170630_cal.xml EX-101.CAL 121695
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20170630_def.xml EX-101.DEF 352746
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20170630_lab.xml EX-101.LAB 861148
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20170630_pre.xml EX-101.PRE 519253
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 171008653
SIC: 2834 Pharmaceutical Preparations